Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYY-mAbs Signs License Agreement with SciClone for DANYELZA® (naxitamab-gqgk) and Omburtamab in ChinaPREV STORYBavarian Nordic Announces Top-line Results from Phase 2 Clinical Trial of BN-Brachyury in Chordoma